Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.

Bibliographic Details
Main Author:	PLOS ONE Editors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6726220?pdf=render

Similar Items

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
by: Tonghai Xing, et al.
Published: (2013-01-01)

Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
by: Yuan-Yuan Liu, et al.
Published: (2015-01-01)

Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection.
by: PLOS ONE Editors
Published: (2019-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
by: Muthusamy, A, et al.
Published: (2008)

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction
by: Muthusamy, A, et al.
Published: (2007)

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Immunosuppression and Liver Transplantation
by: Jan Lerut, et al.
Published: (2023-02-01)

Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma
by: Ramin Raul Ossami Saidy, et al.
Published: (2021-03-01)

The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
by: Safak Gül-Klein, et al.
Published: (2022-06-01)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure.
by: PLOS ONE Editors
Published: (2019-01-01)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
by: Zhuomao Mo, et al.
Published: (2021-02-01)

Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature
by: Giuseppe Tarantino, et al.
Published: (2016-10-01)

Retraction: Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
by: PLOS ONE Editors
Published: (2023-01-01)

Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor
by: Osman KARA, et al.
Published: (2021-12-01)

Retraction: Acute Toxicity and Gastroprotection Studies with a Newly Synthesized Steroid.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients.
by: PLOS ONE Staff
Published: (2017-01-01)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
by: Flechner, S, et al.
Published: (2005)

Retraction: De novo Cancers Following Liver Transplantation: A Single Center Experience in China.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2022-01-01)

Tolerance and minimization of immunosuppressive therapy after liver transplantation
by: O. A. Gerasimova, et al.
Published: (2021-09-01)

Retraction: HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb.
by: PLOS ONE Editors
Published: (2022-01-01)

Immunosuppression for postcardiac transplant patients
by: Dhara Singh
Published: (2018-01-01)

Retraction: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Overexpression of SMS in the tumor microenvironment is associated with immunosuppression in hepatocellular carcinoma
by: Lin Xiang, et al.
Published: (2022-12-01)

Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
by: Yi Bai, et al.
Published: (2022-07-01)

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
by: Roy Andre, et al.
Published: (2010-05-01)

Retraction: Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study.
by: PLOS ONE Editors
Published: (2019-01-01)